Low-melting agarose (e.g. SeaPlaque® agarose, Lonza)
Buffer A: cross-linking buffer; compatible with cross-linker (e.g. not containing primary due to the evaporation rims that prevent adjacent solutions from mixing. Cross-linker (e.g. glutaraldehyde)
Buffer A': buffer A supplemented with cross-linker 1 1 7
Quenching agent (e.g. Tris, glycine, ammonium sulfate) 
Optional step -purification of multi-component complexes prior to cross-linking
Buffer C: buffer suitable for both electrophoresis and protein stability (for example,
Tris/glycine native gel buffer)
High gel strength agarose (e.g. SeaKem® agarose, Lonza)
Horizontal or vertical gel electrophoresis apparatus 1 2 9
Staining and destaining protein solutions (e.g. Coomassie-based) AgarFix requires the use of low-melting agarose, which remains liquid at low temperature 1 3 4
(typically above 30°C). For medium to large complexes (> 0.5 MDa) we use SeaPlaque® NuSieve® agarose (Lonza) can alternatively be used at 1.5 to 2 % final concentration.
The agarose solution is prepared at 1.25X concentration (i.e. 1.25 % for a final concentration either case, the flask containing the solution should be weighted before heating up, and again linker, or quenching agent) is added to the agarose drop and, after incubation, is carefully
pipetted away. (C) Following quenching, the agarose drop is recovered using a spatula. Since melted agarose cools down to room temperature almost instantly, heating of the protein
sample is minimal. Air bubbles may be formed during the mixing process; they are not 1 5 7
detrimental and can help locating the agarose drop during the subsequent steps.
The amounts stated above are given as a guide; the agarose drop size can be up-or
downscaled, and the protein concentration might require optimisation. As a rule of thumb, it aggregates during the cross-linking process, but this is highly protein-dependent; larger 1 6 2 complexes that are prone to aggregation should be kept at low concentrations. when required. The following steps consist of soaking the agarose drop in buffers A, A', and B. This can be
easily achieved by pipetting buffer onto the agarose drop (Fig. 1B) ; we found 125 μ L to be an
ideal volume when using a 96-well plate lid with evaporation rims, but the volume can be
adapted depending on the type of the support used. To remove the solution, the pipette tip is
placed on the side of the rim and the buffer is pipetted away. Care should be taken not to
damage the agarose drop in the process. The lid may be kept on ice, if required for protein
stability.
If the protein was initially in a different buffer not compatible with cross-linking (e.g. containing primary amines), we recommend pre-washing the agarose drop in 3 x 125
buffer A for 3 x 5 min prior to crosslinking.
Cross-linking is achieved by adding to the agarose drop 125 The simplest option to elute the protein from the agarose drop is by diffusion. The agarose
drop is removed from the lid using a small spatula (Fig. 1C ) and placed into a the recovery, we recommend cutting the agarose drop, and pellet the fragments by
centrifugation at 5,000 g for 15 sec. 1 to 2 hours incubation time is sufficient for sample
elution, but this vastly depends on the sample molecular weight and on the A and B buffer composition. If required, the recovery may be increased by filtering the sample using a sample may be centrifuged at 13,000 g for 5 min to pellet the agarose fragments, the Electroelution may also be used, in a buffer suitable for both electrophoresis and protein is placed into a dialysis bag together with 0.2-1 mL buffer C, immersed in cold buffer C in a 2 0 7
horizontal electrophoresis gel unit, and run at 3-5 V/cm for 15 min. Noteworthy, the protein unknown, agarose drop should be centred in the dialysis bag. After electrophoresis, the 2 1 0 protein will be in the bag supernatant, which can be recovered and optionally concentrated. Other recovery methods such as gel nebulisers or freezing should not be used, as they are
generally not gentle enough for fragile protein complexes.
1 3
When cross-linking a sample for the first time, we recommend assessing the absence of aggregates by negative stain EM. Otherwise, the sample can be readily used for cryo-EM grid 2 1 5
preparation. 
Optional step -purification of multi-component complexes prior to cross-linking
When preparing complexes from two or more binding partners, it is recommended to 2 1 8 eliminate unbound partners in order to minimise sample heterogeneity. This can easily be streamlined by adding a gel-purification step prior to cross-linking. To this end, binding SeaKem® agarose (Lonza) may be used to obtain a stronger, easier-to-handle gel. The gel is duplicate lane, using the first lane as a guide. The purified multi-component sample can be
cross-linked using the above-described protocol. sulfate was added to 50 mM for quenching, and sample was immediately used to prepare instructions. After concentration using an Amicon® Ultra 0.5 mL filter, sample was used to 2 5 9
prepare negative stain grids. Buffer A is 500 mM potassium acetate, 50 mM HEPES pH 7.6, On-column cross-linking could not be included here as this protein complex is too fragile and
labile to withstand gel filtration in buffer A or other buffer compatible with aldehyde cross-
linkers.
7 3
In both cases, cross-linking is strictly required to prevent complex denaturation ( Fig. 2A, 2F ).
7 4
Once optimised, cross-linking with AgarFix does not induce aggregates formation (Fig. 2B ,
1 3 2G), as opposed to cross-linking in solution using the same protein concentration (Fig. 2C ).
7 6
Cross-linking with AgarFix or Grafix results in sample devoid of aggregates, as molecules
are kept separated by the agarose matrix or centrifugal force pressure respectively, and gently gradient of cross-linker, respectively (Fig. 2B, 2D, 2G) . However, the GraFix method is time- A critical difference between AgarFix and GraFix is that AgarFix does not require any dense 2 8 7 buffer such as sucrose or glycerol, which are not compatible with cryo-EM grid preparation.
8 8
In our hands, the glycerol removal step has proven to be problematic for large and fragile The respective advantages and drawbacks of different cross-linking methods are outlined in 3 0 2 
--to --
+ + 3 0 6
(1) Might not be feasible when working with labile complexes. (2) Depending on the type of column available (analytical or preparative). (3) Can be adapted to complex purification when adding a gel-purification step prior to cross-3 0 9
linking. Criteria are ranked from --(most negative) to + + (most positive). 
